TITLE:
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults

CONDITION:
Attention Deficit Disorder

INTERVENTION:
Extended-release bupropion hydrochloride

SUMMARY:

      This is a placebo controlled study evaluating the efficacy and safety of medication in
      adults with Attention-Deficit Hyperactivity Disorder (ADHD).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 60 Years
Criteria:

        Inclusion criteria:

          -  Patient must be diagnosed with ADHD.

        Exclusion Criteria:

          -  Patient has a current or past history of seizure disorder, brain injury, anorexia
             nervosa or bulimia.

          -  Patient has a current diagnosis of Major Depressive Disorder (MDD).

          -  Patient has a current primary diagnosis of, or received treatment for, Panic
             Disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD)
             or Acute Stress Disorder within the previous 12 months.

          -  Patient has a lifetime diagnosis of bipolar disorder, schizophrenia or other
             psychotic disorders.

          -  Patient has a positive urine test at screening for presence of illicit drugs or
             alcohol abuse during the past 12 months.
      
